Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Mirtazapine
Genus Pharmaceuticals Ltd
N06AX11
Mirtazapine
30mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030400
1.3.1 SPC, LABELLING AND PACKAGE LEAFLET PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON 1. NAME OF THE MEDICINAL PRODUCT Mirtazapine 15 mg orodispersible tablets Mirtazapine Mirtazapine 30 mg orodispersible tablets Mirtazapine Mirtazapine 45 mg orodispersible tablets Mirtazapine 2. STATEMENT OF ACTIVE SUBSTANCE(S) Each orodispersible tablet contains 15 mg mirtazapine. Each orodispersible tablet contains 30 mg mirtazapine. Each orodispersible tablet contains 45 mg mirtazapine. 3. LIST OF EXCIPIENTS Contains aspartame (E951), see leaflet for further information. 4. PHARMACEUTICAL FORM AND CONTENTS Orodispersible tablet _6 orodispersible tablets _ _18 orodispersible tablets _ _30 orodispersible tablets _ _48 orodispersible tablets _ _90 orodispersible tablets _ _96 orodispersible tablets _ 5. METHOD AND ROUTE(S) OF ADMINISTRATION _ _ Oral use. Read the package leaflet before use. 6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN Keep out of the sight and reach of children. 1.3.1 SPC, LABELLING AND PACKAGE LEAFLET 7. OTHER SPECIAL WARNING(S), IF NECESSARY ------- 8. EXPIRY DATE EXP _ _ 9. SPECIAL STORAGE CONDITIONS ------- 10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ------- 11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Bluefish Pharmceuticals AB, Stockholm, Sweden. 12. MARKETING AUTHORISATION NUMBER(S) Mirtazapine 15 mg Orodispersible Tablets: PL 31774/0013 Mirtazapine 30 mg Orodispersible Tablets: PL 31774/0014 Mirtazapine 45 mg Orodispersible Tablets: PL 31774/0015 13. BATCH NUMBER Lot 14. GENERAL CLASSIFICATION FOR SUPPLY 15. INSTRUCTIONS ON USE ------- 16. INFORMATION IN BRAILLE Mirtazapine 15 mg Mirtazapine 30 mg Mirtazapine 45 mg POM 1.3.1 SPC, LABELLING AND PACKAGE LEAFLET 17. UNIQUE IDENTIFIER – 2D BARCODE_ _ <2D barcode carrying the unique identifier included.> 18. UNIQUE IDENTIFIER - HUMAN READABLE DATA_ _ PC: {number} SN: {number} NN: {number} 1 Read the complete document